Cargando…

XRCC5 cooperates with p300 to promote cyclooxygenase-2 expression and tumor growth in colon cancers

Cyclooxygenase (COX) is the rate-limiting enzyme in prostaglandins (PGs) biosynthesis. Previous studies indicate that COX-2, one of the isoforms of COX, is highly expressed in colon cancers and plays a key role in colon cancer carcinogenesis. Thus, searching for novel transcription factors regulatin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Zhifeng, Zheng, Fufu, Yu, Zhenlong, Hao, Jiajiao, Chen, Miao, Yu, Wendan, Guo, Wei, Chen, Yiming, Huang, Wenlin, Duan, Zhijun, Deng, Wuguo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5648251/ https://www.ncbi.nlm.nih.gov/pubmed/29049411 http://dx.doi.org/10.1371/journal.pone.0186900

Ejemplares similares

Quercetin Suppresses Cyclooxygenase-2 Expression and Angiogenesis through Inactivation of P300 Signaling
por: Xiao, Xiangsheng, et al.
Publicado: (2011)

Small interfering RNA-based molecular therapy of cancers
por: Guo, Wei, et al.
Publicado: (2013)

Melatonin Enhances the Anti-Tumor Effect of Fisetin by Inhibiting COX-2/iNOS and NF-κB/p300 Signaling Pathways
por: Yi, Canhui, et al.
Publicado: (2014)

Activating enhancer-binding protein-2α induces cyclooxygenase-2 expression and promotes nasopharyngeal carcinoma growth
por: Shi, Dingbo, et al.
Publicado: (2014)

Targeting PDK1 with dichloroacetophenone to inhibit acute myeloid leukemia (AML) cell growth
por: Qin, Lijun, et al.
Publicado: (2015)

Ku80 cooperates with CBP to promote COX-2 expression and tumor growth
por: Xiao, Yao, et al.
Publicado: (2015)

RFPL3 and CBP synergistically upregulate hTERT activity and promote lung cancer growth
por: Qin, Yu, et al.
Publicado: (2015)

NMI inhibits cancer stem cell traits by downregulating hTERT in breast cancer
por: Feng, Xu, et al.
Publicado: (2017)

Association of XRCC1, XRCC2 and XRCC3 Gene Polymorphism with Esophageal Cancer Risk
por: Kaur, Jagjeet, et al.
Publicado: (2020)

BPTF promotes hepatocellular carcinoma growth by modulating hTERT signaling and cancer stem cell traits
por: Zhao, Xinrui, et al.
Publicado: (2018)

Significant value of XRCC2 and XRCC9 expression in the prognosis of human ovarian carcinoma
por: Liu, Yi, et al.
Publicado: (2021)

A Meta-Analysis for Association of XRCC1, XRCC2 and XRCC3 Polymorphisms with Susceptibility to Thyroid Cancer
por: Mandegari, Mohammad, et al.
Publicado: (2021)

TFAP2B overexpression contributes to tumor growth and a poor prognosis of human lung adenocarcinoma through modulation of ERK and VEGF/PEDF signaling
por: Fu, Lingyi, et al.
Publicado: (2014)

The NRF2-dependent transcriptional axis, XRCC5/hTERT drives tumor progression and 5-Fu insensitivity in hepatocellular carcinoma
por: Liu, Tianze, et al.
Publicado: (2021)

Prognostic, clinicopathological, and immune correlation of NLRP3 promoter methylation in kidney renal clear cell carcinoma
por: Long, Qian, et al.
Publicado: (2021)

Cyclooxygenase-2 immunohistochemical expression in serrated polyps of the colon
por: Kiedrowski, Miroslaw, et al.
Publicado: (2014)

Keratin 23 promotes telomerase reverse transcriptase expression and human colorectal cancer growth
por: Zhang, Ningning, et al.
Publicado: (2017)

Polymorphism of XRCC1, XRCC3, and XPD Genes and Risk of Chronic Myeloid Leukemia
por: Bănescu, Claudia, et al.
Publicado: (2014)

RBFOX3 Promotes Tumor Growth and Progression via hTERT Signaling and Predicts a Poor Prognosis in Hepatocellular Carcinoma
por: Liu, Tianze, et al.
Publicado: (2017)

Melatonin inhibits AP-2β/hTERT, NF-κB/COX-2 and Akt/ERK and activates caspase/Cyto C signaling to enhance the antitumor activity of berberine in lung cancer cells
por: Lu, Jian-Jun, et al.
Publicado: (2015)

High expression of Y-box-binding protein 1 correlates with poor prognosis and early recurrence in patients with small invasive lung adenocarcinoma
por: Zhao, Shilei, et al.
Publicado: (2016)

Cooperative effects of matrix metalloproteinase and cyclooxygenase-2 inhibition on intestinal adenoma reduction
por: Wagenaar-Miller, R A, et al.
Publicado: (2003)

RAD51, XRCC3, and XRCC2 mutation screening in Finnish breast cancer families
por: Pelttari, Liisa M, et al.
Publicado: (2015)

Polymorphisms of XRCC3 and XRCC7 and Colorectal Cancer Risk in Khorasan Razavi Province, Iran
por: Mehrzad, Jamshid, et al.
Publicado: (2019)

Association of XRCC3, XRCC4, BAX, and BCL-2 Polymorphisms with the Risk of Breast Cancer
por: Ozoran, Emre, et al.
Publicado: (2022)

Ursolic Acid Simultaneously Targets Multiple Signaling Pathways to Suppress Proliferation and Induce Apoptosis in Colon Cancer Cells
por: Wang, Jingshu, et al.
Publicado: (2013)

Polymorphisms of XRCC1 genes and risk of nasopharyngeal carcinoma in the Cantonese population
por: Cao, Yun, et al.
Publicado: (2006)

Use of the XRCC2 promoter for in vivo cancer diagnosis and therapy
por: Chen, Yu, et al.
Publicado: (2018)

DNA Repair Genes and Chronic Myeloid Leukemia: ERCC2 (751), XRCC1 (399), XRCC4-Intron 3, XRCC4 (-1394) Gene Polymorphisms
por: Ozdilli, Kursat, et al.
Publicado: (2021)

The Relationship between XRCC1 and XRCC3 Gene Polymorphisms and Lung Cancer Risk in Northeastern Chinese
por: Guo, Shujie, et al.
Publicado: (2013)

The XRCC1 phosphate-binding pocket binds poly (ADP-ribose) and is required for XRCC1 function
por: Breslin, Claire, et al.
Publicado: (2015)

XRCC2 mutation causes meiotic arrest, azoospermia and infertility
por: Yang, Yongjia, et al.
Publicado: (2018)

Werner syndrome protein positively regulates XRCC4-like factor transcription
por: LIU, DONGYUN, et al.
Publicado: (2014)

Cyclooxygenase 2 Modulates Killing of Cytotoxic T Lymphocytes by Colon Cancer Cells
por: Wang, Quanxin, et al.
Publicado: (2009)

The cyclooxygenases
por: Chandrasekharan, NV, et al.
Publicado: (2004)

Transcriptional coactivator CBP upregulates hTERT expression and tumor growth and predicts poor prognosis in human lung cancers
por: Guo, Wei, et al.
Publicado: (2014)

Aspirin enhances the sensitivity of colon cancer cells to cisplatin by abrogating the binding of NF-κB to the COX-2 promoter
por: Jiang, Wei, et al.
Publicado: (2020)

DNA repair genes XRCC1 and XRCC3 polymorphisms and their relationship with the level of micronuclei in breast cancer patients
por: Santos, Raquel A., et al.
Publicado: (2010)

A Comprehensive Evaluation of the Association between Polymorphisms in XRCC1, ERCC2, and XRCC3 and Prognosis in Hepatocellular Carcinoma: A Meta-Analysis
por: Zhao, Yan, et al.
Publicado: (2019)

Relationship between polymorphisms in homologous recombination repair genes RAD51 G172T、XRCC2 & XRCC3 and risk of breast cancer: A meta-analysis
por: Yu, Jiayang, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_95anjrg8rnqqrlravdb4korub0